EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Insulinoma-associated protein-1: A novel marker for diagnosis of small cell carcinoma of the lung

Sudha Sudha, Saumya Shukla, Hemant Kumar, Nidhi Anand, Ravi Prakash

Journal of Laboratory Physicians · 2026-07-27 · 18 · 377-381

DOI: 10.25259/jlp_197_2024 ↗
AbstractBibliografische Angaben

Abstract

Objectives: Insulinoma-associated protein-1 (INSM-1) has been identified as a novel, robust marker for neuroendocrine differentiation in normal and neoplastic human tissue. This is currently the solitary nuclear neuroendocrine marker in diagnostic immunohistochemistry (IHC). The objectives of the study were to ascertain the utility of INSM-1 in the identification of small cell lung carcinoma (SCLC) and compare its diagnostic efficacy with neuroendocrine markers, namely synaptophysin, chromogranin-A, and CD56 or Neural Cell Adhesion Molecule (NCAM). Materials and Methods: The current case series included 31 cases of SCLC collected retrospectively and prospectively. Immunohistochemical staining for pancytokeratin and thyroid transcription factor-1 (TTF-1) was performed in all cases along with staining for neuroendocrine markers, namely synaptophysin or chromogranin-A. The staining for the supplementary neuroendocrine marker, namely CD-56, was performed in 12 cases. INSM-1 immunohistochemistry was performed in all cases. Statistical analysis: The frequency of expression of INSM-1 was assessed and compared with the frequencies of expression of synaptophysin, chromogranin, and CD-56. A p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →